Visualizing vitreous using Kenalog suspension

Journal of Cataract and Refractive Surgery

Volumn 29, Issue 4, 2003, Pages 645-651

  Burk, Scott E ^a   Da Mata, Andrea P ^a   Snyder, Michael E ^a   Schneider, Susan ^b   Osher, Robert H ^b   Cionni, Robert J ^a  

^a CINCINNATI EYE INSTITUTE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BALANCED SALT SOLUTION; BSS; TRIAMCINOLONE ACETONIDE;

ADULT; ANTERIOR EYE CHAMBER; ARTICLE; CANNULA; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; EVALUATION; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; MALE; PRIORITY JOURNAL; SURGEON; TREATMENT PLANNING; VITREOUS BODY;

EID: 0037389329     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0886-3350(03)00016-6     Document Type: Article

References (39)

1. Berler DK. Intraoperative complications during cataract surgery in the very old. Trans Am Ophthalmol Soc 2000; 98:127-130
2. Yap E-Y, Heng W-J. Visual outcome and complications after posterior capsule rupture during phacoemulsification surgery. Int Ophthalmol 2000; 23:57-60
3. Ng DT, Rowe NA, Francis IC, et al. Intraoperative complications of 1000 phacoemulsification procedures: a prospective study. J Cataract Refract Surg 1998; 24: 1390-1395
4. Shah DP, Krishnan AA, Albanis CV, et al. Visual acuity outcomes following vitreous loss in glaucoma and diabetic patients. Eye 2002; 16:271-274
5. Tan JH, Karwatowski WS. Phacoemulsification cataract surgery and unplanned anterior vitrectomy-is it bad news? Eye 2002; 16:117-120
6. Ionides A, Minassian D, Tuft S. Visual outcome following posterior capsule rupture during cataract surgery. Br J Ophthalmol 2001; 85:222-224
7. Chitkara DK, Smerdon DL. Risk factors, complications, and results in extracapsular cataract extraction. J Cataract Refract Surg 1997; 23:570-574
8. Berrod JP, Sautiere B, Rozot P, Raspiller A. Retinal detachment after cataract surgery. Int Ophthalmol 1996-97; 20:301-308
9. Frost NA, Sparrow JM, Strong NP, Rosenthal AR. Vitreous loss in planned extracapsular cataract extraction does lead to a poorer visual outcome. Eye 1995; 9:446-451
10. Banker AS, Freeman WP. Retinal detachment. Ophthalmol Clin North Am 2001; 14(4):695-704
11. Drolsum L, Haaskjold E. Causes of decreased visual acuity after cataract extraction. J Cataract Refract Surg 1995; 21:59-63
12. Spigelman AV, Lindstrom RL, Nichols BD, Lindquist TD. Visual results following vitreous loss and primary lens implantation. J Cataract Refract Surg 1989; 15:201-204
13. Balent A, Civerchia LL, Mohamadi P. Visual outcome of cataract extraction and lens implantation complicated by vitreous loss. J Cataract Refract Surg 1988; 14:158-160
14. Berger BB, Zweig KO, Peyman GA. Vitreous loss managed by anterior vitrectomy; long-term follow-up of 59 cases. Arch Ophthalmol 1980; 98:1245-1247
15. Kanski JJ, Ramsay JH. Vitrectomy techniques in the management of complications in cataract surgery. Trans Ophthalmol Soc UK 1980; 100:216-218
16. Mamo JG. Late effects of vitreous loss. Ann Ophthalmol 1974; 6:935-941
17. Ruiz RS, Teeters VW. The vitreous wick syndrome; a late complication following cataract extraction. Am J Ophthalmol 1970; 70:483-490
18. Tano Y, Chandler D, Machemer R. Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 1980; 90:810-816
19. McCuen BW II, Bessler M, Tano Y, et al. The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol 1981; 91:785-788
20. Hida T, Chandler D, Arena JE, Machemer R. Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol 1986; 101:190-195
21. Young S, Larkin G, Branley M, Lightman S. Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Exp Ophthalmol 2001; 29:2-6
22. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002; 109:920-927
23. Ranson NT, Danis RP, Ciulla TA, Pratt L. Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration [scientific correspondence]. Br J Ophthalmol 2002; 86:527-579
24. Greenberg PB, Martidis A, Rogers AH, et al. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 2002; 86: 247-248
25. Martidis A, Duker JS, Puliafito CA. Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy. Arch Ophthalmol 2001; 119:1380-1383
26. Jonas JB, Hayler JK, Panda-Jonas S. Intravitreal injection of crystalline cortisone as treatment of pre-phthisical ocular hypotony [letter]. Graefes Arch Clin Exp Ophthalmol 2001; 239:464-465
27. Jonas JB, Hayler JK, Söfker A, Panda-Jonas S. Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone. J Glaucoma 2001; 10:284-287
28. Jonas JB, Söfker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001; 132:425-427
29. Antcliff RJ, Spalton DJ, Stanford MR, et al. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 2001; 108:765-772
30. Jonas JB, Hayler JK, Söfker A, Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol 2001; 131:468-471
31. Jonas JB, Hayler JK, Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy. Br J Ophthalmol 2000; 84: 1064-1067
32. Danis RP, Ciulla TA, Pratt LM, Anliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 2000; 20:244-250
33. Challa JK, Gillies MC, Penfold PL, et al. Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up. Aust NZ J Ophthalmol 1998; 26:277-281
34. Peyman GA, Cheema R, Conway MD, Fang T. Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina 2000; 20: 554-555
35. Burk SE, Da Mata AP, Snyder ME, et al. Indocyanine green-assisted peeling of the retinal internal limiting membrane. Ophthalmology 2000; 107:2010-2014
36. Da Mata AP, Burk SE, Riemann CD, et al. Indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for macular hole repair. Ophthalmology 2001; 108:1187-1192
37. Foster RE, Petersen MR, Da Mata AP, et al. Negative indocyanine green staining of epiretinal membranes. Retina 2002; 22:106-108
38. Macdonald JM, Geroski DH, Edelhauser HF. Effect of inflammation on the corneal endothelial pump and barrier. Curr Eye Res 1987; 6:1125-1132
39. Wingate RJB, Beaumont PE. Intravitreal triamcinolone and elevated intraocular pressure. Aust NZ J Ophthalmol 1999; 27:431-432